Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Simple item page
dc.contributor.authorThompson, Mark G.
dc.contributor.authorNatarajan, Karthik
dc.contributor.authorIrving, Stephanie A.
dc.contributor.authorRowley, Elizabeth A.
dc.contributor.authorGriggs, Eric P.
dc.contributor.authorGaglani, Manjusha
dc.contributor.authorKlein, Nicola P.
dc.contributor.authorGrannis, Shaun J.
dc.contributor.authorDeSilva, Malini B.
dc.contributor.authorStenehjem, Edward
dc.contributor.authorReese, Sarah E.
dc.contributor.authorDickerson, Monica
dc.contributor.authorNaleway, Allison L.
dc.contributor.authorHan, Jungmi
dc.contributor.authorKonatham, Deepika
dc.contributor.authorMcEvoy, Charlene
dc.contributor.authorRao, Suchitra
dc.contributor.authorDixon, Brian E.
dc.contributor.authorDascomb, Kristin
dc.contributor.authorLewis, Ned
dc.contributor.authorLevy, Matthew E.
dc.contributor.authorPatel, Palak
dc.contributor.authorLiao, I-Chia
dc.contributor.authorKharbanda, Anupam B.
dc.contributor.authorBarron, Michelle A.
dc.contributor.authorFadel, William F.
dc.contributor.authorGrisel, Nancy
dc.contributor.authorGoddard, Kristin
dc.contributor.authorYang, Duck-Hye
dc.contributor.authorWondimu, Mehiret H.
dc.contributor.authorMurthy, Kempapura
dc.contributor.authorValvi, Nimish R.
dc.contributor.authorArndorfer, Julie
dc.contributor.authorFireman, Bruce
dc.contributor.authorDunne, Margaret M.
dc.contributor.authorEmbi, Peter
dc.contributor.authorAzziz-Baumgartner, Eduardo
dc.contributor.authorZerbo, Ousseny
dc.contributor.authorBozio, Catherine H.
dc.contributor.authorReynolds, Sue
dc.contributor.authorFerdinands, Jill
dc.contributor.authorWilliams, Jeremiah
dc.contributor.authorLink-Gelles, Ruth
dc.contributor.authorSchrag, Stephanie J.
dc.contributor.authorVerani, Jennifer R.
dc.contributor.authorBall, Sarah
dc.contributor.authorOng, Toan C.
dc.contributor.departmentSchool of Public Health
dc.date.accessioned2024-06-21T15:50:02Z
dc.date.available2024-06-21T15:50:02Z
dc.date.issued2022-01-28
dc.identifier.citationThompson, M. G. (2022). Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance—VISION Network, 10 States, August 2021–January 2022. MMWR. Morbidity and Mortality Weekly Report, 71. https://doi.org/10.15585/mmwr.mm7104e3
dc.identifier.urihttps://hdl.handle.net/1805/41747
dc.language.isoen_US
dc.publisherU.S. Department of Health & Human Services
dc.relation.isversionof10.15585/mmwr.mm7104e3
dc.relation.journalMorbidity and Mortality Weekly Report
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectCOVID-19
dc.subjectmRNA
dc.subjectvaccine effectiveness (VE)
dc.subjectSARS-CoV-2 variants
dc.titleEffectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Thompson2022Effectiveness-PubP.pdf
Size:
482.3 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles